In support of the recent article by Chambers (1), we wish to share our data on the origin of the MDA-MB-435 and M14 cell lines. Chambers claims that it is most plausible that both cell lines represent MDA-MB-435 based on two X chromosomes in the MDA-MB-435 karyotype, whereas M14 had been derived from a man (1). However, karyotyping does not discriminate between paternal and maternal alleles and thus does not exclude loss of the Y chromosome combined with reduplication of the X chromosome. We previously reported an allelotype on human breast cancer cell lines, including MDA-MB-435 (2). Our analyses did not detect Y chromosome sequences and revealed heterozygosity of polymorphic microsatellite markers at Xp, implying that MDA-MB-435 had indeed been derived from a woman. Our MDA-MB-435 cell line was obtained directly from American Type Culture Collection at passage 239 and M14 from its originator at passage 10 (3). We confirmed that the cell lines were identical by microsatellite analysis, in concordance with Rae and colleagues (4), and we also identified unique mutations in the p53 and p16 genes in both cell lines (3). Altogether, it can be concluded conclusively that MDA-MB-435 and M14 are breast cancer cell lines.

